— Know what they know.
Not Investment Advice
Also trades as: 1302.HK (HKSE) · $vol 4M

LFTSF OTC

LifeTech Scientific Corporation
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -31.3%
$0.23
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 53 · $1.0B mcap · 3.58B float · 0.0000% daily turnover

Cash Flow Trends

Operating Cash Flow
$321M -23.1% ▼
5Y CAGR: +3.2%
Capital Expenditures
$283M +3.3% ▲
5Y CAGR: +12.2%
Free Cash Flow
$38M -69.3% ▼
5Y CAGR: -19.8%
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$314M -315.5% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income$243M$333M$378M$176M$199M
Depreciation & Amort.$63M$62M$67M$77M$88M
Stock-Based Comp.$154M$20M$63M$113M$133M
Change in Working Capital$61M$99M-$81M-$27M-$33M
Other Non-Cash Items-$2M-$34M-$38M$80M-$66M
Operating Cash Flow$339M$489M$388M$418M$321M
— Investing Activities —
Capital Expenditures-$158M-$343M-$335M-$201M-$197M
Acquisitions (Net)-$10M-$4M-$10M-$400K-$33M
Investment Purchases-$221M-$317M-$508M-$190M-$596M
Investment Sales$50M$448M$357M$0$360M
Other Investing-$3M$129M$38M-$63M-$52M
Investing Cash Flow-$342M-$87M-$458M-$454M-$518M
— Financing Activities —
Net Debt Issuance-$131M-$174M-$12M-$9M-$7M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$10M$89M$66M$218M$36M
Financing Cash Flow$675M-$256M-$215M$183M-$117M
Net Change in Cash$673M$148M-$285M$146M-$314M
Cash End of Period$972M$1.1B$834M$979M$666M
Free Cash Flow$180M$146M$53M$125M$38M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms